Company Altimmune Inc Nasdaq
Equities
US02155H1014
Biotechnology & Medical Research
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Treatments for Various Diseases and Disorders, and Vaccines
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -726.47% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -726.47% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Vipin K. Garg
CEO | Chief Executive Officer | 67 | 18-11-29 |
Director of Finance/CFO | 66 | 21-12-30 | |
Anthony Blandin
CMP | Compliance Officer | - | 22-01-31 |
M. Roberts
CTO | Chief Tech/Sci/R&D Officer | 65 | 12-11-30 |
Bertrand Georges
CTO | Chief Tech/Sci/R&D Officer | - | 15-02-28 |
M. Harris
CTO | Chief Tech/Sci/R&D Officer | 71 | 19-09-08 |
Karen Smith
PRN | Corporate Officer/Principal | - | 20-08-31 |
Andrew Shutterly
AUD | Comptroller/Controller/Auditor | - | 20-09-30 |
56 | - | ||
Raymond Jordt
PRN | Corporate Officer/Principal | 52 | 22-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Mitchel Sayare
CHM | Chairman | 76 | 10-03-31 |
Mack Gill
BRD | Director/Board Member | 72 | 04-07-31 |
Philip Hodges
BRD | Director/Board Member | 56 | 03-08-31 |
Vipin K. Garg
CEO | Chief Executive Officer | 67 | 18-11-29 |
David Drutz
BRD | Director/Board Member | 86 | 09-12-31 |
Wayne Pisano
BRD | Director/Board Member | 69 | 18-08-29 |
Diane Jorkasky
BRD | Director/Board Member | 72 | 20-05-10 |
Catherine Sohn
BRD | Director/Board Member | 71 | 23-03-22 |
Klaus Schafer
BRD | Director/Board Member | 74 | 12-06-30 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 70,902,191 | 70,351,925 ( 99.22 %) | 0 | 99.22 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+18.15% | 124B | |
+18.02% | 112B | |
+5.07% | 22.94B | |
-12.75% | 22.22B | |
-9.86% | 17.02B | |
-14.97% | 16.88B | |
-39.94% | 16.87B | |
+2.80% | 13.63B | |
+27.39% | 11.61B |